Emcure Pharmaceuticals Ltd Cash Flow Quality Index
Emcure Pharmaceuticals Ltd cash flow quality index. Emcure Pharmaceuticals Ltd (EMCURE) has a Cash Flow Quality Index of 0.57x as of September 2025. Operating cash flow of Rs2.56 Billion is below net income of Rs4.50 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Emcure Pharmaceuticals Ltd (EMCURE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Emcure Pharmaceuticals Ltd (2022–2026)
Cash flow quality index of Emcure Pharmaceuticals Ltd from 2022 to 2026. Historical Cash Flow Quality Index for Emcure Pharmaceuticals Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Emcure Pharmaceuticals Ltd balance sheet quality to measure how much of total assets are equity-financed.
Emcure Pharmaceuticals Ltd Cash Flow Quality Index by Year (2022–2026)
Emcure Pharmaceuticals Ltd cash flow quality index by year from 2022 to 2026. Year-by-year earnings quality comparison for Emcure Pharmaceuticals Ltd. For the full cash flow conversion analysis, see EMCURE operating cash flow.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 0.92x | Rs8.51 Billion | Rs9.24 Billion | ▲ +4.9% |
| 2025 | 0.88x | Rs8.52 Billion | Rs9.71 Billion | ▼ -60.2% |
| 2024 | 2.20x | Rs10.97 Billion | Rs4.98 Billion | ▲ +56.9% |
| 2023 | 1.40x | Rs7.47 Billion | Rs5.32 Billion | ▲ +21.0% |
| 2022 | 1.16x | Rs7.68 Billion | Rs6.62 Billion | — |